European Journal of Cancer
European Journal of Cancer is a peer-reviewed oncology journal published by Elsevier on behalf of the European Organisation for Research and Treatment of Cancer and the European Society of Breast Cancer Specialists, founded in 1965 and issuing eighteen issues a year, indexed in the Science Citation Index Expanded, Scopus and MEDLINE, with a 2025 impact factor of 7.9European Journal of Cancer 是由 Elsevier 代表欧洲癌症研究与治疗组织与欧洲乳腺癌专科医师学会出版的同行评审肿瘤学期刊,1965 年创刊,每年出版 18 期,被科学引文索引扩展版、Scopus 与 MEDLINE 收录,2025 年影响因子为 7.9。
Scope
- Clinical oncology across medical, paediatric, radiation and surgical subspecialties内科、儿童、放射与外科等临床肿瘤学各亚专科。
- Translational and preclinical oncology including carcinogenesis and tumour biology涵盖癌变机制与肿瘤生物学的转化与临床前肿瘤学。
- Cancer epidemiology and prevention research癌症流行病学与预防研究。
- Therapeutic innovation and patient care in cancer treatment癌症治疗中的治疗创新与患者照护。
- Prognostic and predictive biomarkers reported under the REMARK guidelines预后与预测生物标志物研究,报告须遵循 REMARK 规范。
History
- The journal traces its origin to European Journal of Cancer founded in 1965 under ISSN 0014-2964该刊源头可追溯至 1965 年创刊的 European Journal of Cancer(旧刊号 0014-2964)。
- It was renamed European Journal of Cancer & Clinical Oncology in 19811981 年更名为 European Journal of Cancer & Clinical Oncology。
- The title European Journal of Cancer returned in 1990 under the current ISSN 0959-80491990 年恢复现名 European Journal of Cancer,现刊号为 0959-8049。
- It has been published by Elsevier and has issued eighteen issues a year since 2000该刊由 Elsevier 出版,自 2000 年起每年出版 18 期。
Editors
- The editor-in-chief is Alexander M. M. Eggermont of Institut Gustave Roussy in Paris现任主编为法国巴黎 Institut Gustave Roussy 的 Alexander M. M. Eggermont。
- It is the official journal of the European Organisation for Research and Treatment of Cancer and the European Society of Breast Cancer Specialists该刊是欧洲癌症研究与治疗组织与欧洲乳腺癌专科医师学会的官方期刊。
- Manuscripts are reviewed under a single anonymized peer review process稿件采用单盲同行评审流程。
- The journal is hybrid open access, offering an open access option alongside the subscription model该刊为混合开放获取,在订阅模式之外提供开放获取选项。